Provider review
Oria Meds review
Names neither molecule publicly — the drug appears after your address is collected.
The public pages sell an unnamed GLP-1 from two figures that match nothing offered afterwards.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated September 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Oria Meds
$199/mo sema · $369/mo tirz — only inside the intake
- Vs median
- $27/mo above the $172 median
- Market
- $59–$1300/mo across 254 of 393
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by PerfectRx — 503A appears only in unrendered code
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Nothing on the public pages says which drug is for sale. Two from-prices are advertised against an unnamed GLP-1 and an unnamed dual agonist, and neither figure appears again once the intake begins; the plans that actually exist show up at step three, after a name, an email address, a phone number and a shipping address have been collected, at figures well above the advertised ones. The semaglutide ladder is the wrong way up, with three and six months both working out dearer per month than paying month to month, so committing longer is the more expensive choice. What the intake does supply is genuinely useful: the weekly milligram behind each plan is stated, and the multi-month options are described as gradual starts with the dose steps written out. The compounding pharmacy is named with a full address, which is more than most sellers manage, though its compounding class exists only inside code the page never renders and a reader is told only that it is licensed. No legal entity, governing law or clinician is published anywhere.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are willing to hand over contact details to see a price, and want the weekly milligram stated when you do
- You want the dispensing pharmacy named with an address before you order
- You want a titration schedule written out rather than left to a message after purchase
Look elsewhere if
- You want to know what drug you are buying before giving a name, an email address and an address
- You are budgeting from the advertised figures, which match nothing the intake offers
- You are considering a longer plan: three and six months both cost more per month than paying monthly
What it actually costs
Price as published
No GLP-1 price is readable before the intake. The front page sells a compounded GLP-1 "starting at $149" and a compounded dual GIP/GLP-1 "starting at $249", neither attached to a named drug and neither matching anything offered afterwards · the plans that are actually sold appear at step three, after name, email, phone and shipping address: compounded semaglutide with B12 at $199/month billed monthly, a three-month gradual-start plan at $209/month and a six-month at $209/month · compounded tirzepatide with B12 at $369/month, $316/month over three and $299/month over six · ⚠ the semaglutide ladder is INVERTED — committing to three or six months costs MORE per month than paying monthly · the doses are stated inside the intake, 0.25 mg weekly semaglutide and 2.5 mg weekly tirzepatide, and nowhere on the public site
- Vs median
- $27/mo above the $172 median across the 254 of 393 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
157 of the 393 programs we track price a small dose this way. Neither molecule is named anywhere on the public site and no low-dose product is offered; the plans, their prices and their doses appear at step three of the intake, after name, email, phone and shipping address. The multi-month semaglutide plans cost more per month than paying monthly, so committing longer is the more expensive choice.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- September 2026
What it does well
- Names PerfectRx as the compounding pharmacy with a street address, phone number and web address
- The intake states the weekly milligram behind each plan rather than selling an unlabeled dose
- The multi-month plans are described as gradual starts with the dose steps written out
- Free shipping, an injection kit and dose increases are stated as included in the monthly figure
- Month-to-month is genuinely month-to-month: the plan renews until canceled with no minimum term
Pharmacy, labs and oversight
Oria Meds dispenses through a PerfectRx — 503A appears only in unrendered code facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Oria Meds publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Oria Meds sells compounded semaglutide and compounded tirzepatide, and never says so anywhere a reader can see before handing over contact details. The public pages advertise a compounded GLP-1 from $149 and a compounded dual GIP/GLP-1 from $249, name no molecule, and neither figure appears again once the intake begins; the plans that exist are $199 a month for semaglutide and $369 for tirzepatide, and they show up at step three, after a name, an email address, a phone number and a shipping address have been collected. The semaglutide ladder is the wrong way up: the three-month and six-month plans both work out at $209 a month against $199 for paying month to month, so committing longer costs more. What the intake does supply is the dose — 0.25 mg weekly semaglutide, 2.5 mg weekly tirzepatide, with the multi-month plans described as gradual starts that step up. PerfectRx is named as the compounding pharmacy with a full address, though the 503A designation exists only inside unrendered code and a reader is told only that it is a licensed compounding pharmacy. No legal entity, governing law or clinician is published.
The honest cons
NEITHER MOLECULE IS NAMED ANYWHERE ON THE PUBLIC SITE — the drug appears at step two of the intake, after name, email, phone and shipping address
- The advertised $149 and $249 match nothing that is sold; the plans offered are $199 and $369
- The semaglutide ladder is inverted — three and six months both cost $209 a month against $199 for paying monthly
- A second price table lives in the front page's own code and renders nowhere, quoting figures that contradict the live ones
- The 503A designation appears only in unrendered code; a reader is told only that the pharmacy is licensed
- Two different scarcity counters run on consecutive screens, and the review turnaround is given as 24 hours in one place and 48 in another
- Medication is not refundable once dispensed, including unopened vials, while the page says cancel anytime
- No legal entity, governing law, arbitration clause or clinician is published anywhere
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Oria Meds is one of 393 low-dose GLP-1 programs we track, and 254 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#389 of 393
Ordered with the companies that pay us first, and Oria Meds is not one of them. A disclosed partition, not a score.
Compare all 393 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Titrating up from a microdose
- What the evidence actually shows
- The true annual cost of a plan
- Microdose & reconstitution calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $22/mo above the $172 median
- Market
- $59–$1300/mo across 254 of 393
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.